Contact Us

HIV-COVID Database

Coronavirus Under Research Exclusion

Contact Us

HIV-COVID Database

Coronavirus Under Research Exclusion

HIV-COVID Database

Coronavirus Under Research Exclusion

Contact Us

Current Data

Current Data

We will be updating our data biweekly as new reports continue to come in.

 

Last Updated: 05/15/2020

Total Number of Cases Reported: 35

Report a Case

 

Cases Reported by State (U.S. only)*

State Reported Cases
ARIZONA 2
CALIFORNIA 7
CONNECTICUT 3
INDIANA 1
PENNSYLVANIA 1
MASSACHUSETTS 2
TEXAS 1
MARYLAND 10

*States not included in this table have not reported any cases to CURE HIV-COVID

 

Cases and Outcomes by Patient Characteristics

Characteristic TOTAL Number % Hospitalized Supportive Care (no supplemental O2) in Hospital Supplemental O2 High Flow O2 Mechanical Ventilator ECMO Resolved Symtomatic not Hospitalized Symptomatic Remains Hospitalized Deceased
Overall 35 34% 20% 20% 0% 60% 33% 53% 18% 18% 12%
Age
18-29 years 
30-39 years  7 0% 0% 0% 0% 0% 0% 100% 0% 0% 0%
40-49 years  11 36% 50% 25% 0% 25% 0% 55% 27% 0% 9%
50-59 years  10 40% 25% 25% 0% 50% 0% 60% 10% 20% 0%
60-69 years  4 50% 0% 0% 0% 50% 0% 25% 25% 50% 0%
70-79 years  1 0% 0% 0% 0% 0% 0% 100% 0% 0% 0%
>=80 years  2 100% 0% 0% 0% 100% 0% 0% 0% 0% 100%
Sex
Male  24 33% 33% 14% 0% 43% 0% 63% 17% 4% 13%
Female  10 40% 40% 25% 0% 50% 0% 60% 0% 30% 0%
Male-to-Female Trans 1 0% 0% 0% 0% 0% 0% 0% 100% 0% 0%
Race
Arab
Black 16 44% 29% 0% 0% 57% 0% 50% 6% 25% 6%
East Asian
South Asian
West Asian
Middle Eastern
Pacific Islander 1 0% 0% 0% 0% 0% 0% 0% 100% 0% 0%
Latin American
Caucasian 14 36% 25% 50% 0% 25% 0% 72% 14% 0% 14%
Native American
Aboriginal
First Nations
Other 3 33% 67% 23% 0% 0% 0% 67% 23% 0% 0%
Unknown 1 100% 0% 0% 0% 100% 0% 100% 0% 0% 0%
Average CD4 Count 460 Hosp. vs 648 Not Hosp
% CD4 Pre-Covid/During Covid/Not Available 94/0/6
Average HIV VL 107 Hosp vs <20 Not Hosp
% HI VL Pre-Covid/During Covid/Not Available 94/0/6
AIDS 13 38% 20% 20% 0% 60% 0% 69% 8% 15% 8%
Never Met AIDS Criteria 7 2% 33% 33% 0% 0% 33% 56% 19% 6% 6%
Not Known 2 50% 0% 0% 0% 40% 0% 50% 0% 0% 50%
COVID Treatment
Remdesivir
Lopinavir/ritonavir
Chloroquine
Hydroxychloroquine 6 67% 0% 33% 0% 67% 0% 62% 14% 10% 7%
Hydroxychloroquine + Azithromycin 3 0% 0% 0% 0% 0% 0% 33% 33% 0% 33%
Azithromycin 6 50% 0% 0% 0% 100% 0% 33% 17% 33% 17%
IL-6 inhibitors
Bevacizumab
JAK inhibitor
Serpin inhibitor
Ciclesonide
Glucocorticoids (including if given for any complications) 3 100% 0% 33% 0% 67% 0% 33% 9% 33% 33%
IVIG
Plasma from recovered patients
Therapeutic Anticogulation
None 22 9% 50% 50% 0% 0% 0% 75% 13% 6% 0%
Unknown 1 100% 0% 0% 0% 100% 0% 0% 0% 0% 100%
Other